Patent · US Active

System and method for prostate treatment

US11911499B2 · kind B2 · utility

0Cited by

27References

24Claims

0Family size

Assignee

Resurge Therapeutics, Inc. · US

Inventors

Olof Mikael Trollsas · San Jose, US
John Stankus · Plano, US
Shahram Shawn Gholami · Monte Sereno, US

Key dates

Filing date	Nov 6, 2020
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Jul 20, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A minimally invasive treatment of benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. A method includes introducing a composition into the prostate to achieve a sustained release of the cytostatic or cytotoxic drug over a period of between about 14 days and 12 months.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.